Piramal Enterprises acquires the brand CALADRYL in India
Piramal Enterprises Limited (formerly Piramal Healthcare Limited) has announced that it has acquired the over-the-counter (OTC) brand CALADRYL® in India from Valeant Pharmaceuticals International, Inc.
The brand CALADRYL in India was owned by Valeant Pharmaceuticals International, Inc
(“Valeant”). The rights to this brand were acquired by Valeant from Johnson & Johnson in the year 2012. CALADRYL® is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching.
This acquisition enables Piramal Enterprises (“PEL”) to widen its consumer products portfolio in the skin care segment. PEL’s current consumer products portfolio includes brands such as Lacto Calamine, Saridon, i-Pill, Itchmosol and Supractiv Complete, along with niche market brands like i-Pill, i-Can, Jungle Magic, Tetmosol and Triactiv. The division has one of India’s largest field forces in the industry covering more than 100,000 towns.